Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in db/db Mice Using Cytokine Antibody Array

Table 3

The relative expression changes of 29 cytokines.

Number	Cytokines	Model group (expt. week 12)/model group (expt. week 0)	LST group (expt. week 12)/model group (expt. week 0)	TSF group (expt. week 12)/model group (expt. week 0)
1	VEGF	0.94	0.97	0.75
2	VEGF R2	0.90	1.48	0.64
3	IGFBP-3	1.13	1.05	0.96
4	SCF	0.95	1.00	0.67
5	IL-2	1.52	1.47	1.01
6	IL-4	3.72	3.73	2.02
7	IL-6	1.61	1.26	1.32
8	IL-13	1.19	1.14	0.96
9	IL-15	1.05	0.82	0.83
10	FAS ligand	0.99	0.78	0.65
11	ICAM-1	0.54	0.69	0.42
12	VCAM-1	0.35	0.42	0.24
13	PF4	0.93	0.67	0.56
14	TIMP-1	0.99	1.05	0.73
15	IFN-gamma	1.76	1.70	1.51
16	Decorin	2.02	1.88	1.56
17	TNF-alpha	1.50	1.26	1.27
18	IL-3	0.76	0.68	0.51
19	IL-7	1.37	1.18	1.01
20	IL-10	0.74	0.63	0.59
21	IL-17	0.74	0.65	0.54
22	MCP-1	0.64	0.59	0.41
23	M-CSF	0.70	0.64	0.53
24	CD36	0.74	0.63	0.49
25	EGF	0.59	0.36	0.75
26	IGFBP-2	0.74	0.65	0.98
27	IGF-II	0.64	0.59	0.86
28	MMP-2	0.70	0.64	0.95
29	E-cadherin	1.05	1.01	1.23